Startup
A
ANRis
siRNA design technology to selectively silence mutant genes.
Funding rounds
Grey amounts aren't counted in totals. † includes debt or other non-equity.
| Date | Company | Stage | Amount | Investors | Sector |
|---|---|---|---|---|---|
| 7 Sept 2026 | AANRis | Undisclosed | ¥220M | Waseda University VenturesJapan Science and Technology Agency | BiotechDeep tech |